From October 1, 2023 to December 31, 2023, the company has repurchased 5,983,233 shares, representing 0.99% for $444.26 million. With this, the company has completed the repurchase of 18,921,321 shares, representing 3.09% for $1,450.43 million under the buyback announced on July 28, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.22 USD | +0.08% | +5.76% | +17.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.48% | 53.72B | |
+12.25% | 227B | |
+15.52% | 197B | |
+18.39% | 141B | |
+30.60% | 110B | |
+0.53% | 64.15B | |
+6.33% | 51.75B | |
+10.96% | 45.2B | |
+6.51% | 37.37B | |
+26.64% | 32.11B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on July 28, 2022.